ATM Inhibitors in Cancer Radiotherapy: Mechanisms, Clinical Development, and Future Directions
<p>Ataxia-telangiectasia mutated (ATM) kinase plays a pivotal role in the cellular response to DNA damage. Under normal conditions, ATM acts as a tumor suppressor by regulating pathways that lead to apoptosis and cell cycle arrest via effectors like p53, p21, CHK1, and CHK2. Paradoxically, in...
Saved in:
| Main Author: | Raed.M. Al-Zoubi (22254577) (author) |
|---|---|
| Other Authors: | Khalil Garada (22254580) (author), Reem Al Huneidi (22254583) (author), Zaid M.H. Baddar (22254586) (author), Ayman A. Zarour (17917709) (author), Mai Elaarag (17807390) (author), Sally R. Al-Zoubi (22254589) (author), Ahmad R. Al-Qudimat (17337808) (author), Mazhar Salim Al Zoubi (18024364) (author), Abdelali Agouni (181926) (author), Khalid Alrumaihi (14779210) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of radiotherapy in newly diagnosed primary CNS lymphoma: A descriptive review and a pragmatic approach to clinical practice
by: Venkada Manickam Gurusamy (21792914)
Published: (2022) -
Identification of a potential DNA methyltransferase (DNMT) inhibitor
by: Zainab Jan (17306614)
Published: (2023) -
Delineating and sparing functional nephrons for radiotherapy in the case of lymphoma with polycystic kidney disease
by: Venkada Manickam Gurusamy (17346805)
Published: (2022) -
Immune checkpoint inhibitors: recent progress and potential biomarkers
by: Pramod Darvin (153341)
Published: (2018) -
Menin inhibitors in KMT2A-rearranged and NPM1-mutated acute leukemia: A scoping review of safety and efficacy
by: Sara Al Dali (22504094)
Published: (2025)